Prescription drug · ANDA
Ultramicrosize Griseofulvin (Griseofulvin) NDC 62135-494
Griseofulvin 125 mg/1 · Tablet · Oral · Chartwell RX, LLC.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 62135-494-01 | 6213504940162135049401 | 100 TABLET in 1 BOTTLE, PLASTIC (62135-494-01)Marketed from Nov 30, 2020 | |
| 62135-494-30 | 6213504943062135049430 | 30 TABLET in 1 BOTTLE, PLASTIC (62135-494-30)Marketed from Nov 30, 2020 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Ultramicrosize Griseofulvin
- Generic name (nonproprietary)
- griseofulvin
- Active ingredients
- Griseofulvin — 125 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Chartwell RX, LLC.NDC labeler code 62135
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 061996
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Mitosis (Physiologic effect)Microtubule Inhibition (Physiologic effect)
- Identifiers
- Product ID 62135-494_459d8a07-072f-744c-e063-6394a90a9d87SPL ID 459d8a07-072f-744c-e063-6394a90a9d87SPL set ID efb8a660-802c-4ca6-bbff-ad7b48b91aefRxCUI 239239, 242831UNII 32HRV3E3D5UPC 0362135494308, 0362135495305
- Pharmacologic class
- Tubulin Inhibiting Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N462135049401followed by a unit qualifier and the quantityPackage 62135-0494-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Ultramicrosize griseofulvin tablets are indicated for the treatment of the following ringworm infections; tinea corporis (ringworm of the body), tinea pedis (athlete’s foot), tinea cruris (ringworm of the groin and thigh), tinea barbae (barber’s itch), tinea capitis (ringworm of the scalp), and tinea unguium (onychomycosis, ringworm of the nails), when caused by one or more of the following genera of fungi: Trichophyton rubrum , Trichophyton tonsurans, Trichophyton mentagrophytes, Trichophyton interdigitalis, Trichophyton verrucosum, Trichophyton megnini, Trichophyton gallinae, Trichophyton crateriform, Trichophyton sulphureum, Trichophyton schoenleini, Microsporum audo…
Excerpt only. Read the full label for complete information.
About NDC 62135-494
- What is NDC 62135-494?
- 62135-494 is the product NDC for Ultramicrosize Griseofulvin (griseofulvin), Griseofulvin 125 mg/1 tablet, listed with the FDA by Chartwell RX, LLC.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Ultramicrosize Griseofulvin (Griseofulvin).
- What is the active ingredient?
- Griseofulvin.
- Who is the labeler?
- Chartwell RX, LLC., NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Ultramicrosize Griseofulvin?
- 11 other product NDCs are listed under this name. See all Ultramicrosize Griseofulvin NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Ultramicrosize Griseofulvin products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Ultramicrosize Griseofulvingriseofulvin | Griseofulvin 125 mg/1 | TabletOral | Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | 23155-863 | 23155-0863-01 |
| Ultramicrosize Griseofulvingriseofulvin | Griseofulvin 250 mg/1 | TabletOral | Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | 23155-864 | 23155-0864-01 |
| Ultramicrosize Griseofulvin | Griseofulvin 125 mg/1 | Tablet, CoatedOral | Sandoz Inc | 0781-5827 | 00781-5827-0100781-5827-05 |
| Ultramicrosize Griseofulvin | Griseofulvin 250 mg/1 | Tablet, CoatedOral | Sandoz Inc | 0781-5828 | 00781-5828-0100781-5828-05 |
| Ultramicrosize Griseofulvinultramicrosize griseofulvin tablets | Griseofulvin 125 mg/1 | Tablet, CoatedOral | Amneal Pharmaceuticals of New York LLC | 0115-1724 | 00115-1724-0100115-1724-02 |
| Ultramicrosize Griseofulvinultramicrosize griseofulvin tablets | Griseofulvin 250 mg/1 | Tablet, CoatedOral | Amneal Pharmaceuticals of New York LLC | 0115-1725 | 00115-1725-0100115-1725-03 |
| Ultramicrosize Griseofulvin | Griseofulvin 125 mg/1 | TabletOral | Sigmapharm Laboratories, LLC | 42794-013 | 42794-0013-08 |
| Ultramicrosize Griseofulvin | Griseofulvin 250 mg/1 | TabletOral | Sigmapharm Laboratories, LLC | 42794-014 | 42794-0014-08 |
| Ultramicrosize Griseofulvingriseofulvin | Griseofulvin 250 mg/1 | TabletOral | Chartwell RX, LLC. | 62135-495 | 62135-0495-0162135-0495-30 |
| Ultramicrosize Griseofulvin | Griseofulvin 165 mg/1 | TabletOral | Chartwell RX, LLC | 62135-501 | 62135-0501-30 |
Other NDCs under ANDA 061996
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Ultramicrosize Griseofulvingriseofulvin | Griseofulvin 125 mg/1 | TabletOral | Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | 23155-863 |
| Ultramicrosize Griseofulvingriseofulvin | Griseofulvin 250 mg/1 | TabletOral | Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | 23155-864 |
| Ultramicrosize Griseofulvingriseofulvin | Griseofulvin 250 mg/1 | TabletOral | Chartwell RX, LLC. | 62135-495 |
| Ultramicrosize Griseofulvin | Griseofulvin 165 mg/1 | TabletOral | Chartwell RX, LLC | 62135-501 |
| Ultramicrosize Griseofulvin | Griseofulvin 165 mg/1 | TabletOral | Ayurax, LLC. | 73308-435 |